Anxiety symptoms and functioning in a community sample of individuals with type 2 diabetes: A longitudinal study

Journal of Diabetes

Volumn 8, Issue 6, 2016, Pages 854-862

  Deschênes, Sonya S ^a,b   Burns, Rachel J ^a,b   Schmitz, Norbert ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

Author keywords

anxiety; community sample; functioning; path analysis; type 2 diabetes

Indexed keywords

ADL DISABILITY; ADULT; AGED; ANXIETY; ANXIETY ASSESSMENT; ARTICLE; BODY MASS; COHORT ANALYSIS; DEPRESSION; DISEASE DURATION; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SMOKING; SOCIAL STATUS; STRUCTURAL EQUATION MODELING;

EID: 84990937888     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12368     Document Type: Article

References (41)

1. International Diabetes Federation (IDF). IDF Diabetes Atlas, 6th ed. International Diabetes Federation, Brussels, 2013.
2. Pouwer F, Kupper N, Adriaanse MC. Does emotional stress cause type 2 diabetes mellitus? A review from the European Depression in Diabetes (EDID) Research Consortium. Discov Med. 2010; 9: 112–8.
3. Smith KJ, Béland M, Clyde M, et al. Association of diabetes with anxiety: A systematic review and meta-analysis. J Psychosom Res. 2013; 74: 89–99. DOI:10.1016/j.jpsychores.2012.11.013.
4. Engum A The role of depression and anxiety in onset of diabetes in a large population-based study. J Psychosom Res. 2007; 62: 31–8. DOI:10.1016/j.jpsychores.2006.07.009.
5. Peyrot M, Rubin RR. Levels and risks of depression and anxiety symptomatology among diabetic adults. Diabetes Care. 1997; 20: 585–90.
6. Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: A systematic review. J Psychosom Res. 2002; 53: 1053–60.
7. Spitzer RL, Kroenke K, Williams JB, Lowe BA. brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med. 2006; 166: 1092–7. DOI:10.1001/archinte.166.10.1092.
8. Gregg EW, Mangione CM, Cauley JA et al. Diabetes and incidence of functional disability in older women. Diabetes Care. 2002; 25: 61–7.
9. Wong E, Backholer K, Gearon E et al. Diabetes and risk of physical disability in adults: A systematic review and meta-analysis. Lancet Diabetes Endocrinol. 2013; 1: 106–14.
10. Üstün TB. Measuring Health and Disability: Manual for WHO Disability Assessment Schedule WHODAS 2.0. World Health Organization, Geneva, 2010.
11. Teesson M, Mitchell PB, Deady M, Memedovic S, Slade T, Baillie A. Affective and anxiety disorders and their relationship with chronic physical conditions in Australia: Findings of the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry. 2011; 45: 939–46. DOI:10.3109/00048674.2011.614590.
12. Smith KJ, Schmitz N. Association of depression and anxiety symptoms with functional disability and disability days in a community sample with type 2 diabetes. Psychosomatics. 2014; 55: 659–67. DOI:10.1016/j.psym.2014.05.015.
13. Brown LA, Krull JL, Roy-Byrne P et al. An examination of the bidirectional relationship between functioning and symptom levels in patients with anxiety disorders in the CALM study. Psychol Med. 2015; 45: 647–61.
14. Scholten WD, Batelaana NM, van Balkoma AJLM, Penninxa BWJH, Smita JH, van Oppen P. Recurrence of anxiety disorders and its predictors. J Affect Disord. 2013; 147: 180–5.
15. Iancu S, Batelaan NM, Zweekhorst MB et al. Trajectories of functioning after remission from anxiety disorders: 2-year course and outcome predictors. Psychol Med. 2014; 44: 593–605.
16. Sherbourne CD, Hays RD, Ordway L, DiMatteo MR, Kravitz RL. Antecedents of adherence to medical recommendations: Results from the Medical Outcomes Study. J Behav Med. 1992; 15: 447–68.
17. Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol. 2001; 57: 457–78.
18. Peyrot M, Rubin RR, Lauritzen T, Snoek FJ, Matthews DR, Skovlund SE. Psychosocial problems and barriers to improved diabetes management: Results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabet Med. 2005; 22: 1379–85.
19. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003; 289: 3095–105. DOI:10.1001/jama.289.23.3095.
20. Lamers F, van Oppen P, Comijs HC et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: The Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry. 2011; 72: 341–8. DOI:10.4088/JCP.10m06176blu.
21. Schmitz N, Gariépy G, Smith KJ et al. Longitudinal relationships between depression and functioning in people with type 2 diabetes. Ann Behav Med. 2014; 47: 172–9.
22. Smith KJ, Gariépy G, Pedneault M, Beland M, Clyde M, Schmitz N. Exploring the association of psychological status with self-rated diabetes control: Results from the Montreal evaluation of diabetes treatment study. Psychosomatics. 2013; 54: 35–43. DOI:10.1016/j.psym.2012.08.002.
23. Lowe B, Decker O, Müller S et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008; 46: 266–74. DOI:10.1097/MLR.0b013e318160d093.
24. Garin O, Ayuso-Mateos JL, Almansa J et al. Validation of the “World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases. Health Qual Life Outcomes. 2010; 8: 51.
25. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001; 16: 606–13.
26. Rubin RR, Peyrot M. Quality of life and diabetes. Diabetes Metab Res Rev. 1999; 15: 205–18.
27. Collins M, Corcoran P, Perry I. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009; 26: 153–61.
28. Stewart AL, Hays RD, Wells KB, Rogers WH, Spritzer KL, Greenfield S. Long-term functioning and well-being outcomes associated with physical activity and exercise in patients with chronic conditions in the Medical Outcomes Study. J Clin Epidemiol. 1994; 47: 719–30.
29. Acock AC. Discovering Structural Equation Modeling Using Stata. Stata Press books, College Station, TX, 2013.
30. McEwen BS. Stress, adaptation, and disease: Allostasis and allostatic load. Ann N Y Acad Sci. 1998; 840: 33–44.
31. Ghojazadeh M, Taghizadeh M, Abdi S, Azami-Aghdash S, Andalib S, Farhoudi M. Fear of disease progression in patients with multiple sclerosis: Associations of anxiety, depression, quality of life, social support and knowledge. J Clin Res Gov. 2014; 3: 141–6.
32. Ducat L, Philipson LH, Anderson BJ. The mental health comorbidities of diabetes. JAMA. 2014; 312: 691–2.
33. Fisher L, Skaff MM, Mullan JT, Arean P, Glasgow R, Masharani U. A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with type 2 diabetes. Diabet Med. 2008; 25: 1096–101.
34. Hutter N, Vogel B, Alexander T, Baumeister H, Helmes A, Bengel J. Are depression and anxiety determinants or indicators of quality of life in breast cancer patients? Psychol Health Med. 2013; 18: 412–9. DOI:10.1080/13548506.2012.736624.
35. Hays RD, Marshall GN, Wang EYI, Sherbourne CD. Four-year cross-lagged associations between physical and mental health in the Medical Outcomes Study. J Consult Clin Psychol. 1994; 62: 441–9.
36. Orlando M, Tucker JS, Sherbourne CD, Burnam MA. A cross-lagged model of psychiatric problems and health-related quality of life among a national sample of HIV-positive adults. Med Care. 2005; 43: 21–7.
37. Smedstad L, Vaglum P, Moum T, Kvien T. The relationship between psychological distress and traditional clinical variables: A 2 year prospective study of 216 patients with early rheumatoid arthritis. Rheumatology. 1997; 36: 1304–11.
38. Anderson RJ, Grigsby AB, Freedland KE et al. Anxiety and poor glycemic control: A meta-analytic review of the literature. Int J Psychiatry Med. 2002; 32: 235–47.
39. The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the Diabetes Control and Complications Trial. Diabetes 1995; 44: 968–983.
40. Klein R, Klein BEK. Relation of glycemic control to diabetic microvascular complications in diabetes mellitus. Ann Intern Med. 1996; 124: 90–6.
41. Gaster B, Hirsch IB. The effects of improved glycemic control on complications in type 2 diabetes. Arch Intern Med. 1998; 158: 134–40.